The recent FDA approvals for donanemab (Kinsunla®) and lecanemab (Leqembi®) for the treatment of Alzheimer’s mark a major step forward for dementia research. While these treatments focus on Alzheimer’s, they offer hope for Parkinson’s disease as well.
… Full Story>
Every month, Stanford Parkinson’s Community Outreach produces a list of Parkinson’s-related webinars and virtual meetings with speakers. Here’s our August 2024 list.
… Full Story>
Todos los meses, Stanford Parkinson’s Community Outreach producirá una lista de seminarios web y reuniones virtuales en español relacionados con el Parkinson con oradores. Aquí está nuestra lista de Agosto de 2024.
… Full Story>
Stanford Neurology, in collaboration with SRI, is looking for people with Parkinson’s disease (PD) and healthy volunteers, between the ages of 50 and 80. The goal of this research is to learn more about changes in cognition and motor function with aging.
… Full Story>
This episode of “Let’s Keep Moving with APDA” brings you expert advice, tips, and tricks to help you get around your home safely and steadily. Register now for this free American Parkinson Disease Association (APDA) webinar, taking place on August 6, 10am PT.
… Full Story>